Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has closed a $20 million Series D equity financing. Collegium is focused on building a portfolio of pain products that incorporate its patent protected DETERx formulation platform that provides for sustained release and tamper resistance. The Company also through its subsidiary, Onset Therapeutics develops […]
Less
More
Tyrell, Inc., the creators of Zeno, an innovative hand-held medical device used in the treatment of acne, today announced that the company has closed a $28 million round of equity financing. Established in Houston, Texas, in September 2002, Tyrell, Inc. is the leading pioneer in the category of personal medical devices. The company was formed […]
Creabilis Therapeutics SpA, an emerging specialty pharmaceutical company focused on dermatology, today announces that it has raised 20 million Eur ($31.5 mm) in a Series A round of funding. Creabilis’ vision is to discover and develop innovative new medicines to address dermatological diseases and to market these directly to specialist physicians using its own sales […]
The Swedish pharmaceutical company Moberg Derma AB, which focuses on skin diseases, has completed a new issue generating SEK 40 million ($6.5 million). Moberg Derma develops dermatological pharmaceuticals to treat common skin diseases. The company has two products in phase III clinical trials - K101 which is a topical treatment for nail fungus and K301 […]
Therative Inc., which unveiled its ThermaClear acne treatment device in February, said Wednesday it has closed a new round of private financing that raised $9 million ThermaClear, the privately held company’s first consumer product, is a handheld device for treatment of mild-to-moderate inflammatory acne. It uses “pulse technology,” similar to the laser treatments dermatologists […]
Neosil, a Pharmaceutical Company Developing Dermatological Treatments Hercules Provides $10 Million Financing In addition to its topical hair growth product, NEOSH101, Neosil is developing a broad-spectrum topical anti-microbial agent for acne and anti-infective use
AGI Dermatics, a privately held biopharmaceutical company focused on skin cancer prevention drugs and anti-aging topical skincare products, today announced it has raised $5.5 million in a Series A private equity round
IVREA Pharmaceuticals, an emerging specialty pharmaceutical company focusing on dermatology, today announced it raised $11 million from existing investors Atlas Venture and Easton Capital and new investor CHL Medical Partners. IVREA Pharmaceuticals is developing products having significant medical and patient advantages in the treatment of onychomycosis and acne.
Magen BioSciences, Inc., a biotechnology company developing agents to promote the health and appearance of human skin, announced today that it has secured $1.8 million in a seed investment round
acne
BioTechnology